27 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
is committed to appointing individuals from inside and outside the Company by keeping balance of nationality, gender, work history, age, race, ethnicity … to the Company’s Board of Directors (12 males and three females) and considers diversity, including gender, age, work history, race, ethnicity and cultural
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
individuals from inside and outside the Company by keeping balance of nationality, gender, work history, age, race, ethnicity, and cultural background … females) and considers diversity, including gender, age, work history, race, ethnicity and cultural background, in the nomination of directors
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
and society. We also measure our progress on DE&I, starting with focusing on enterprise-wide gender representation. 82% 37% Upskilling Employees … % (Male) 51.8% (Female) 0.2% (Other / Non-binary) Embracing DE&I (Gender Representation) Enterprise-wide gender breakdown P L A N E T Reducing Scope 1 & 2
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:19am
and innovation rooted in our patient-focused values. We are consistently working to advance the diversity of the Board, including in gender
6-K
TAK
Takeda Pharmaceutical Co
30 Mar 23
Current report (foreign)
6:19am
of the Nomination Committee commented “Takeda is highly committed to advancing the diversity of the Board, including gender, nationalities, skills and experiences
6-K
eb3v3engz
11 Jul 22
Current report (foreign)
6:05am
6-K
EX-99.1
pk4mbc3cgjju18idnx
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
na3vqcs2
31 May 22
Current report (foreign)
6:07am
6-K
ohqcof l5ih3mh74aulj
11 May 22
Current report (foreign)
6:06am
6-K
da086vfr
1 Apr 22
Current report (foreign)
6:14am
6-K
n1sz2lv3s xi7ev3xh32
1 Nov 21
Current report (foreign)
6:04am
6-K
14y8nfl6
19 Jul 21
Current report (foreign)
6:02am
6-K
EX-99.1
69h9dqfv 5qvyyqau4
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
87g5vxmj prpqoy8ogej
28 May 21
Current report (foreign)
6:04am
6-K
EX-99.1
qg26m g6lc
6 Apr 21
Current report (foreign)
6:29am
6-K
EX-99.1
wf8m wbr6n6
17 Dec 20
Current report (foreign)
6:01am
6-K
8ox913o
29 Jul 20
Current report (foreign)
6:07am
6-K
EX-1
f2i z8fuv61hgy
27 May 20
Current report (foreign)
6:03am
6-K
EX-99.1
kaq6oljx9pzvi6xh9
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am